Alpha 2.0
Login Register
» Authors » Jim Janinis

Jim Janinis

Explore the profile of Jim Janinis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 28
Followers 0
Related Specialties
Oncology
Biomedical Engineering
Top 10 Co-Authors
Eleftherios Zygouris
Jubrail Dahabreh
Christos Damaskos
Pagona Sklapani
Aikaterini Pierrakou
Nikolaos Trakas
George Fountzilas
Demetrios A Spandidos
Nikolaos Garmpis
Christos Nikokiris
Published In
Anticancer Res
Cureus
Cancer Invest
Mol Clin Oncol
Anticancer Drugs
Affiliations
Soon will be listed here.
Recent Articles
1.
Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival
Georgakopoulou V, Zygouris E, Papalexis P, Gkoufa A, Damaskos C, Pierrakou A, et al.
Oncol Lett . 2022 Aug; 24(3):313. PMID: 35949610
Pulmonary carcinoid tumors are rare, low-grade malignant tumors that constitute 1-2% of all lung tumors. The present study aimed to describe the simultaneous pathological findings in biopsy specimens of patients...
2.
Prognostic value of the immunohistochemistry markers CD56, TTF-1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors
Georgakopoulou V, Zygouris E, Damaskos C, Pierrakou A, Papalexis P, Garmpis N, et al.
Mol Clin Oncol . 2022 Jan; 16(2):31. PMID: 34984102
Lung carcinoid tumor is a type of neuroendocrine tumor, which is subdivided into typical carcinoid (TC) and atypical carcinoid (AT), based on the rate of mitosis and the presence of...
3.
Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center
Georgakopoulou V, Zygouris E, Nikokiris C, Damaskos C, Pierrakou A, Garmpis N, et al.
Cureus . 2020 Sep; 12(9):e10300. PMID: 32923302
Introduction Lung carcinoid tumors are neuroendocrine neoplasms, less frequent than other lung tumors. They are subdivided into typical carcinoids (TC) and atypical carcinoids (AC), according to the rate of mitosis...
4.
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)
Janinis J, Stathopoulos G, Nikolaidis P, Kalofonos H, Kalogera-Fountzila A, Samantas E, et al.
Anticancer Drugs . 2004 May; 15(5):479-87. PMID: 15166622
A phase I pharmacokinetics and dose-finding study and a phase II study of the combination of pegylated liposomal doxorubicin HCl (PLD) and paclitaxel were conducted in patients with recurrent or...
5.
Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer
Razis E, Kosmidis P, Aravantinos G, Bakoyiannis C, Janinis J, Timotheadou H, et al.
Cancer Invest . 2004 Apr; 22(1):10-5. PMID: 15069759
Purpose: 5-Fluorouracil (5-FU) and Vinorelbine (Vin) are active in the second line therapy of metastatic breast cancer (MBC). We conducted a multi-institutional phase II study to assess the activity of...
6.
Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients
Galani E, Sgouros J, Petropoulou C, Janinis J, Aravantinos G, Skarlos D, et al.
Anticancer Res . 2002 Aug; 22(4):2275-80. PMID: 12174914
The development of a molecular screening method for cancer patients is of great importance, since it would contribute to the selection of the most effective chemotherapy regimen for each patient....